Elevated Total Bilirubin on Admission is a Marker of Worse 30- and 180-Day Outcomes for Patients With Acute HF: Insights From ASCEND-HF

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Samsky, M; Dunning, A; Schulte, P; DeVore, A; Mentz, R; Patel, C; Starling, R; Teerlink, J; Tang, W; Armstrong, P; Ezekowitz, J; Metra, M; Voors, A; McMurray, J; Butler, J; O'Connor, C; Hernandez, A

Published Date

  • August 2015

Published In

Volume / Issue

  • 21 / 8

Start / End Page

  • S120 - S121

International Standard Serial Number (ISSN)

  • 1071-9164

Digital Object Identifier (DOI)

  • 10.1016/j.cardfail.2015.06.346